Senti Biosciences Holdings (SNTI) Receivables - Net (2021 - 2026)
Senti Biosciences Holdings' Receivables - Net was $600,000 in Q2 2026, down 91.7% from $7.19 million a year earlier.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Receivables - Net (2021 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Senti Biosciences Holdings came in at $1.6 million, down 11.6% from FY2024.
- Receivables - Net shows a four-year compound annual growth rate of 34.8% (FY2021 to FY2025).
- In earlier years, Receivables - Net was $1.81 million in FY2024 (-89.8%), $17.7 million in FY2023, $626,000 in FY2022 (+29.6%) and $483,000 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Receivables - Net since Q2 2023.
- Compared with a year earlier, Receivables - Net was higher in 1 of the last seven quarters, with an average decline of 33.8%.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2025 (growth of 200.4%); the worst was Q3 2024 (a decline of 94.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Senti Biosciences Holdings | 9.65 Mn | 9.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 600,000.00 |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 18.66 Mn |
| Mar 31, 2024 | 17.92 Mn |
| Dec 31, 2023 | 17.70 Mn |
| Sep 30, 2023 | 18.62 Mn |
| Jun 30, 2023 | 567,000.00 |
| Mar 31, 2023 | 791,000.00 |
| Dec 31, 2022 | 626,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 573,000.00 |
| Dec 31, 2021 | 483,000.00 |
API Access
Senti Biosciences Holdings Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SNTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SNTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SNTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();